Search research articles
Contact Us
Filters
Showing results (131-140 of 183) with videos related to
Page
of 19
Sort By:
Investigational New Drugs
|
June 20, 2014
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer
Emiliano Calvo, Victor J Chen, Mark Marshall, et al.
JTO Clinical and Research Reports
|
April 13, 2026
Treatment Patterns, Outcome, and Quality of Life of Patients With Extensive-Stage SCLC Receiving Third-Line Therapy-Data From the German CRISP Registry (AIO-TRK-0315): A Brief Report
Maximilian Rost, Rieke Fischer, Martin Reck, et al.
International Journal of Cardiology
|
June 7, 2015
Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock
Han S Lim, Nick Andrianopoulos, Hariharan Sugumar, et al.
International Journal of Cancer
|
March 24, 2026
Prediction of the individual risk for the development of brain metastases in patients with non-oncogene-addicted non-small cell lung cancer: Real-world data from the German prospective CRISP registry (AIO-TRK-0315)
Fabian Acker, Katharina Wenger, Martin Reck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 3, 2026
Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315)
Friederike C Althoff, Horst-Dieter Hummel, Konrad Kokowski, et al.
Breast Cancer Research and Treatment
|
March 31, 2010
Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer
Marcus Schmidt, Ilka Brigitte Petry, Daniel Böhm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2008
Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer
John V Heymach, Luis Paz-Ares, Filippo De Braud, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
April 7, 2020
Incidence and risk factors for stroke following percutaneous coronary intervention
Luke P Dawson, Justin A Cole, Terase F Lancefield, et al.
JTO Clinical and Research Reports
|
April 8, 2024
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)
Frank Griesinger, Martin Sebastian, Wolfgang M Brueckl, et al.
Plos Pathogens
|
November 13, 2024
ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization
Lu Zhang, Hsiu-Hsin Cheng, Nadine Krüger, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 183) with videos related to
Sort By:
Page
of 19
Investigational New Drugs
|
June 20, 2014
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer
Emiliano Calvo, Victor J Chen, Mark Marshall, et al.
JTO Clinical and Research Reports
|
April 13, 2026
Treatment Patterns, Outcome, and Quality of Life of Patients With Extensive-Stage SCLC Receiving Third-Line Therapy-Data From the German CRISP Registry (AIO-TRK-0315): A Brief Report
Maximilian Rost, Rieke Fischer, Martin Reck, et al.
International Journal of Cardiology
|
June 7, 2015
Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock
Han S Lim, Nick Andrianopoulos, Hariharan Sugumar, et al.
International Journal of Cancer
|
March 24, 2026
Prediction of the individual risk for the development of brain metastases in patients with non-oncogene-addicted non-small cell lung cancer: Real-world data from the German prospective CRISP registry (AIO-TRK-0315)
Fabian Acker, Katharina Wenger, Martin Reck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 3, 2026
Institutional variability in testing for actionable genetic alterations in patients with stage IIIB/C or IV non-small cell lung cancer: A real-world study from the German prospective, observational, multicenter CRISP registry (AIO-TRK-0315)
Friederike C Althoff, Horst-Dieter Hummel, Konrad Kokowski, et al.
Breast Cancer Research and Treatment
|
March 31, 2010
Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer
Marcus Schmidt, Ilka Brigitte Petry, Daniel Böhm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2008
Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer
John V Heymach, Luis Paz-Ares, Filippo De Braud, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
April 7, 2020
Incidence and risk factors for stroke following percutaneous coronary intervention
Luke P Dawson, Justin A Cole, Terase F Lancefield, et al.
JTO Clinical and Research Reports
|
April 8, 2024
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)
Frank Griesinger, Martin Sebastian, Wolfgang M Brueckl, et al.
Plos Pathogens
|
November 13, 2024
ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization
Lu Zhang, Hsiu-Hsin Cheng, Nadine Krüger, et al.
Page
of 19